Pascal Deschatelets - Net Worth and Insider Trading
Pascal Deschatelets Net Worth
The estimated net worth of Pascal Deschatelets is at least $20 Million dollars as of 2025-05-19. Pascal Deschatelets is the Chief Scientific Officer of Apellis Pharmaceuticals Inc and owns about 1,147,716 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $20 Million. Details can be seen in Pascal Deschatelets's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pascal Deschatelets has not made any transactions after 2025-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Pascal Deschatelets
Pascal Deschatelets Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pascal Deschatelets owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Pascal Deschatelets’s form 4 insider trades.
Insider Ownership Summary of Pascal Deschatelets
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2025-01-29 | Chief Operating Officer |
Pascal Deschatelets Latest Holdings Summary
Pascal Deschatelets currently owns a total of 1 stock. Pascal Deschatelets owns 1,147,716 shares of Apellis Pharmaceuticals Inc (APLS) as of January 29, 2025, with a value of $20 Million.
Latest Holdings of Pascal Deschatelets
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2025-01-29 | 1,147,716 | 17.45 | 20,027,644 |
Holding Weightings of Pascal Deschatelets
Pascal Deschatelets Form 4 Trading Tracker
According to the SEC Form 4 filings, Pascal Deschatelets has made a total of 33 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 33 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 826 shares on January 29, 2025, which brought Pascal Deschatelets around $24,384.
Insider Trading History of Pascal Deschatelets
- 1
Pascal Deschatelets Trading Performance
Pascal Deschatelets Ownership Network
Ownership Network List of Pascal Deschatelets
Ownership Network Relation of Pascal Deschatelets

Pascal Deschatelets Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Pascal Deschatelets is the Chief Operating Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , General Counsel David O. Watson , and Senior Vice President Mark Jeffrey Delong .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Pascal Deschatelets made 11 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 232,500. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 35,769 shares made by David O. Watson , a net sale of 311,716 shares made by Cedric Francois , and a net sale of 33,815 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 5,752 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 5,752 shares. During the past 18 months, 960,256 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 960,256 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Pascal Deschatelets Mailing Address
Above is the net worth, insider trading, and ownership report for Pascal Deschatelets. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Pascal Deschatelets's mailing address is: Crestwood Ky 40014.